Osborne Clarke advised Basecamp Research Ltd on the deal. Basecamp Research Ltd (“Basecamp”), a company that designs protein products based on the largest knowledge graph of...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Turbine on the deal. Turbine, a company developing a cell behavior simulation platform, has announced the closing of a €20 million Series A...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised WG Partners LLP, Panmure Gordon (UK) Limited and Stifel Nicolaus Europe Limited. WG Partners LLP, Panmure Gordon (UK) Limited and Stifel Nicolaus...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised the shareholders of The Research Partnership Limited on the deal. The Research Partnership Limited (Research Partnership) on its acquisition by Ashfield Huntsworth for...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Uniphar plc on the deal. Uniphar plc acquired UK-based brand commercialisation and pharmaceutical marketing agency, Events4Healthcare. E4H offers a wide range of...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Uniphar plc on the deal. Uniphar plc acquired UK-based pharmaceutical distributor Devonshire Healthcare Services (“Devonshire”). Devonshire has provided access to unlicensed and...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Grifols on the deal. Grifols signed an agreement with the Hong Kong’s Tiancheng International Investment Ltd. to acquire 100% of the shares...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Science Create Ventures, Foresight Williams Technology and BGF. The £1.5m investment round included Science Create Ventures, Foresight Williams Technology, BGF and The Cambridge Angels. This...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Science Creates Ventures on the deal. SCV invested into University of Bristol spin-out CytoSeek, SCV’s first investment since announcing the launch of the fund....
You must be a Standard 1 Year member to access this content.
